chitosan has been researched along with moxifloxacin in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 8 (42.11) | 24.3611 |
| 2020's | 8 (42.11) | 2.80 |
| Authors | Studies |
|---|---|
| Bogataj, M; Kerec, M; Mrhar, A; Veranic, P | 1 |
| Bogataj, M; Kos, MK; Mrhar, A; Veranic, P | 1 |
| Cardile, V; Crupi, E; Giannone, I; Musumeci, T; Puglisi, G; Tommasini, S; Ventura, CA | 1 |
| Dadashzadeh, S; Haeri, A; Mahboubi, A; Mortazavi, A; Sohrabi, S | 1 |
| Dubey, J; Nayak, AK; Verma, A; Verma, N | 1 |
| Jena, PK; Mehta, T; Prajapati, B; Seshadri, S | 1 |
| Kumar, A; Singh, B | 1 |
| Devi, VK; Mustafa, S; Pai, RS | 1 |
| Al-Waeli, H; Ganguly, A; Ian, CK; Meka, VS; Sahu, PS; Sheshala, R | 1 |
| Fatima, N; Murtaza, G; Shah, A; Yameen, MA | 1 |
| Ali Buabeid, M; Arafa, EA; Hussain, I; Li, L; Murtaza, G; Shah, A | 1 |
| Chhibber, T; Gondil, VS; Sinha, VR | 1 |
| Abdeltawab, NF; Awad, GAS; Ishak, RAH; Nasr, M; Radwan, NH | 1 |
| Abbas, G; Afzal, Z; Ashfaq, M; Hanif, M; Iqbal, O; Rasul, A; Shah, S | 1 |
| Abd El-Alim, SH; Asfour, MH; Awad, GEA; Kassem, AA | 1 |
| Abbas, G; Hameed, M; Khan, IU; Latif, S; Rasool, M; Rasul, A; Shah, PA; Siddique, MI; Waqas, MK; Yousaf, AM | 1 |
| Kesavan, K; Mohan, P; Rangari, VD | 1 |
| Asad, M; Dong, Z; Hou, Z; Li, M; Younas, A; Zhang, N | 1 |
| Biswas, S; Ch, S; Ghosh, B; Padaga, SG; Roy, S | 1 |
19 other study(ies) available for chitosan and moxifloxacin
| Article | Year |
|---|---|
Permeability of pig urinary bladder wall: the effect of chitosan and the role of calcium.
Topics: Animals; Aza Compounds; Calcium; Chitosan; Fluoroquinolones; Microscopy, Electron, Scanning; Moxifloxacin; Permeability; Quinolines; Swine; Urinary Bladder | 2005 |
Permeability of pig urinary bladder wall: time and concentration dependent effect of chitosan.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Chitosan; Dose-Response Relationship, Drug; Fluoroquinolones; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Moxifloxacin; Permeability; Quinolines; Swine; Urinary Bladder | 2006 |
Chitosan microspheres for intrapulmonary administration of moxifloxacin: interaction with biomembrane models and in vitro permeation studies.
Topics: Anti-Bacterial Agents; Aza Compounds; Calorimetry, Differential Scanning; Cell Line; Cell Membrane Permeability; Chitosan; Fluoroquinolones; Humans; Microscopy, Electron, Scanning; Microspheres; Moxifloxacin; Quinolines | 2008 |
Chitosan gel-embedded moxifloxacin niosomes: An efficient antimicrobial hybrid system for burn infection.
Topics: Anti-Infective Agents; Burns; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Fluoroquinolones; Gels; Infections; Microbial Sensitivity Tests; Moxifloxacin; Particle Size; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Viscosity | 2016 |
Chitosan-Hydroxypropyl Methylcellulose Matrices as Carriers for Hydrodynamically Balanced Capsules of Moxifloxacin HCl.
Topics: Chitosan; Drug Carriers; Drug Liberation; Fluoroquinolones; Hydrodynamics; Hypromellose Derivatives; Molecular Structure; Moxifloxacin | 2017 |
Preparation and Optimization of Moxifloxacin Microspheres for Colon Targeted Delivery Using Quality by Design Approach: In Vitro and In Vivo Study.
Topics: Animals; Anti-Bacterial Agents; Chitosan; Colon; Drug Compounding; Drug Delivery Systems; Drug Design; Drug Liberation; Escherichia coli; Excipients; Feces; Fluoroquinolones; Ileum; Kinetics; Lacticaseibacillus casei; Male; Microspheres; Moxifloxacin; Rats, Wistar; Spectroscopy, Fourier Transform Infrared | 2016 |
Radiation formation of functionalized polysaccharide-protein based skin mimicking semi- inter penetrating network for biomedical application.
Topics: Acrylic Resins; Animals; Anti-Bacterial Agents; Bandages, Hydrocolloid; Chitosan; Drug Compounding; Drug Liberation; Fluoroquinolones; Gamma Rays; Gelatin; Goats; Intestine, Small; Kinetics; Moxifloxacin; Oxygen; Permeability; Polyvinyl Alcohol; Skin, Artificial; Tensile Strength; Water; Wounds, Penetrating | 2016 |
Effect of PEG and water-soluble chitosan coating on moxifloxacin-loaded PLGA long-circulating nanoparticles.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Chitosan; Drug Carriers; Drug Liberation; Fluoroquinolones; Lactic Acid; Male; Microscopy, Electron, Transmission; Moxifloxacin; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Wistar; Solubility; Tissue Distribution; Topoisomerase II Inhibitors; Water | 2017 |
Application of diverse natural polymers in the design of oral gels for the treatment of periodontal diseases.
Topics: Administration, Oral; Aggregatibacter actinomycetemcomitans; Anti-Infective Agents; Biological Products; Chitosan; Diffusion; Fluoroquinolones; Gels; Humans; Hydrogen-Ion Concentration; Karaya Gum; Materials Testing; Moxifloxacin; Periodontal Diseases; Polymers; Streptococcus mutans; Surface Properties; Viscosity | 2017 |
Chemical synthesis of chitosan/silver nanocomposites films loaded with moxifloxacin: Their characterization and potential antibacterial activity.
Topics: Animals; Chitosan; Drug Carriers; Drug Liberation; Microbial Sensitivity Tests; Moxifloxacin; Nanocomposites; Particle Size; Physical Phenomena; Rats; Silver; Skin Absorption; Surface Properties | 2019 |
The wound healing and antibacterial potential of triple-component nanocomposite (chitosan-silver-sericin) films loaded with moxifloxacin.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bandages; Burns; Chitosan; Drug Liberation; Male; Moxifloxacin; Nanocomposites; Rats, Sprague-Dawley; Sericins; Silver; Skin; Skin Absorption; Wound Healing | 2019 |
Development of Chitosan-Based Hydrogel Containing Antibiofilm Agents for the Treatment of Staphylococcus aureus-Infected Burn Wound in Mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Biofilms; Boswellia; Burns; Chitosan; Drug Compounding; Gels; Hydrogels; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moxifloxacin; Staphylococcal Infections; Staphylococcus aureus; Wound Infection | 2020 |
Chitosan-calcium phosphate composite scaffolds for control of post-operative osteomyelitis: Fabrication, characterization, and in vitro-in vivo evaluation.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Calcium Phosphates; Cell Line; Chitosan; Drug Carriers; Humans; Moxifloxacin; Osteoblasts; Osteomyelitis; Rabbits; Tissue Scaffolds | 2020 |
Moxifloxacin loaded nanoparticles of disulfide bridged thiolated chitosan-eudragit RS100 for controlled drug delivery.
Topics: Acrylic Resins; Animals; Caco-2 Cells; Calorimetry, Differential Scanning; Cell Survival; Chitosan; Delayed-Action Preparations; Disulfides; Drug Delivery Systems; Drug Liberation; Humans; Hydrodynamics; Kinetics; Moxifloxacin; Nanoparticles; Particle Size; Proton Magnetic Resonance Spectroscopy; Rats; Spectroscopy, Fourier Transform Infrared; Static Electricity; Sulfhydryl Compounds; Thermogravimetry | 2021 |
Chitosan/β-glycerophosphate in situ forming thermo-sensitive hydrogel for improved ocular delivery of moxifloxacin hydrochloride.
Topics: Animals; Chitosan; Glycerophosphates; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogels; Male; Moxifloxacin; Rabbits; Temperature | 2021 |
Fabrication of moxifloxacin HCl-loaded biodegradable chitosan nanoparticles for potential antibacterial and accelerated cutaneous wound healing efficacy.
Topics: Anti-Bacterial Agents; Chitosan; Drug Carriers; Drug Liberation; Moxifloxacin; Nanoparticles; Particle Size; Wound Healing | 2022 |
Cationic Chitosan/Pectin Polyelectrolyte Nanocapsules of Moxifloxacin as Novel Topical Management System for Bacterial Keratitis.
Topics: Animals; Anti-Bacterial Agents; Chitosan; Cornea; Delayed-Action Preparations; Fluoroquinolones; Keratitis; Moxifloxacin; Nanocapsules; Particle Size; Pectins; Polyelectrolytes; Rabbits | 2022 |
A chitosan/fucoidan nanoparticle-loaded pullulan microneedle patch for differential drug release to promote wound healing.
Topics: Animals; Chitosan; Drug Liberation; Mice; Moxifloxacin; Nanoparticles; Polysaccharides; Wound Healing | 2023 |
Chitosan-poly(lactide-co-glycolide)/poloxamer mixed micelles as a mucoadhesive thermo-responsive moxifloxacin eye drop to improve treatment efficacy in bacterial keratitis.
Topics: Animals; Anti-Bacterial Agents; Chitosan; Humans; Keratitis; Mice; Micelles; Moxifloxacin; Ophthalmic Solutions; Poloxamer; Polyglactin 910; Staphylococcus aureus; Treatment Outcome | 2023 |